Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
10/2003
10/09/2003US20030191213 Novel flame retarding compounds
10/09/2003US20030191163 Substituted cyclic amine metalloprotease inhibitors
10/09/2003US20030191149 Compounds for treating fibromyalgia and chronic fatigue syndrome
10/09/2003US20030191136 Melanin concentrating hormone receptor ligands
10/09/2003US20030191132 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191126 Psychological disorders; antidepressants
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030191117 Acyclic piperazine and piperidine derivatives
10/09/2003US20030191115 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
10/09/2003US20030191112 Novel substituted piperidines
10/09/2003US20030191110 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191098 Synergistic mixture of thalidomide antiinflammatory agnets
10/09/2003CA2480686A1 Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
10/09/2003CA2479930A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
10/09/2003CA2479764A1 Hemiasterlin derivatives and uses thereof
10/09/2003CA2479618A1 Spirocyclic amides as cannabinoid receptor modulators
10/08/2003EP1350108A2 Method for identifying a ligand for a biological substrate
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003CN1447794A Novel compounds
10/08/2003CN1447793A Prodrugs to NMDA receptor ligands
10/08/2003CN1447791A 10-aryl-11-hbenzo [b] fluorene derivatives and analogs for medicinal use
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630494 Treatment for central degenerative disorders, brain power disorders, depressions, and for prophylaxis of cerebral circulatory disorders
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003US6630487 Treatment of insulin resistance with growth hormone secretagogues
10/07/2003US6630473 Anti-inflammatory agents and inhibitors against increase in ocular tension caused by irradiation with lasers, containing 1,4-dihydropyridine derivatives
10/07/2003CA2263957C Diarylmethyl piperazine derivatives as delta opioid agonists
10/07/2003CA2250077C Use of (+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol in treating depressive disorders and bipolar disorders
10/07/2003CA2107105C Heterocyclic-cyclic amine derivatives
10/07/2003CA2094808C Oxysulfonyl urea acat inhibitors
10/02/2003WO2003080631A2 Plasma carboxypeptidase b inhibitors
10/02/2003WO2003080586A1 N-sulfonylurea apoptosis promoters
10/02/2003WO2003080574A1 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
10/02/2003WO2003080564A1 Menthol substituted antithrombotic pai-1 inhibitors
10/02/2003WO2003080060A1 Substituted piperazine antithrombotic pai-1 inhibitors
10/02/2003WO2003079984A2 Substituted tetracycline compounds
10/02/2003WO2003079975A2 Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams
10/02/2003WO2003045912A8 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
10/02/2003WO2003044015A3 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
10/02/2003WO2003042173A8 Nk1 antagonists
10/02/2003WO2003010160A3 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists
10/02/2003US20030187269 Novel process
10/02/2003US20030187147 Reacting a iminoester with polymer
10/02/2003US20030187037 Cardiovascular disorders; antiinflammatory agents; antitumor agents
10/02/2003US20030187023 Sulfone derivatives, process for their production and use thereof
10/02/2003US20030187022 Pain management; analgesics
10/02/2003US20030187021 Treatment of CNS disorders using CNS target modulators
10/02/2003US20030187020 Chemical compounds
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030186964 Piperdines for use as orexin receptor antagonists
10/02/2003US20030186963 Central nervous system disorders; cardiovascular disorders
10/02/2003US20030186961 Central nervous system disorders; vision defects
10/02/2003US20030186943 Substituted gamma-phenyl-delta-lactams and uses related thereto
10/02/2003CA2714873A1 Plasma carboxypeptidase b inhibitors
10/02/2003CA2479887A1 Piperidine or 8-aza-bicyclo¬3.2.1|oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
10/01/2003EP1348697A1 Process for the preparation of S(-)-amlodipine-L(+)-hemitartrate
10/01/2003EP1348692A1 Process for the preparation of amine oxides
10/01/2003EP1347968A1 Lfa-1 antagonist compounds
10/01/2003EP1347960A1 Process for preparing ( ) trans-4-p-fluorophenyl-3-hydroxymethyl-1
10/01/2003EP1347760A2 Nmda receptor agonist pharmaceutical compositions
10/01/2003EP1000029B1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
10/01/2003EP0891331B1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity
10/01/2003EP0846759B1 Gene encoding protein having asymmetric hydrolase activity on 4-substituted-1,4-dihydropyridine derivatives and expression product of the same
10/01/2003CN1446211A Indole derivatives useful for treatment of CNS disorders
10/01/2003CN1446200A Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-ichibiting anti-inflammatory and immune-suppressive agents
09/2003
09/30/2003US6627767 Controlling cellular metabolism
09/30/2003US6627653 Anticonvulsant derivatives useful for the treatment of depression
09/30/2003US6627644 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists
09/30/2003US6627629 Useful for the treatment or prevention of asthma and other allergic diseases.
09/30/2003CA2245768C Methods for treating emesis and central nervous system disorders using optically pure (+) norcisapride
09/30/2003CA2102697C Pyrrolidine derivatives, preparation thereof and drugs containing same
09/25/2003WO2003078421A1 Piperidine derivatives useful as modulators of chemokine receptor activity
09/25/2003WO2003078395A1 Piperidine derivatives useful as modulators of chemokine receptor activity
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2003029199A9 Benzene derivatives, process for preparing the same and use thereof
09/25/2003WO2002100829A9 Process for the preparation of paroxetine substantially free of alkoxy impurities
09/25/2003WO2002004433A3 Melanin concentrating hormone receptor ligands
09/25/2003US20030181489 For therapy and prophylaxis of cough in warm-blooded animals
09/25/2003US20030181484 New substituted pyridine or piperidine compounds
09/25/2003US20030181466 Synthesis of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
09/25/2003US20030181441 Tumor necrosis factor-alpha converting enzyme antagonists, such as (2S,3S)-4-(4-(3,5-difluro-benzyloxy)-benzenesulfonyl) -2-methyl-thiomorpholine-3-carboxylic acid hydroxyamide, used as antiarthritic or anticarcinogenic agents
09/25/2003US20030181440 Isonipecotamides for the treatment of integrin-mediated disorders
09/25/2003US20030181390 Sustained release of aminobutyric acid using prodrugs such as L-1-naphthylalanine-gabapentin, administered for prophylaxis of nervous system disorders, as anxiolytics, antidepressants or antiinflammatory agents; drug delivery
09/25/2003US20030181319 Process for preparing nonracemic chiral alcohols
09/25/2003US20030181318 Process for preparing nonracemic chiral alcohols
09/24/2003EP1346995A1 Process for the preparation of ring compounds
09/24/2003EP1345906A2 Method for producing 4-haloalkyl nicotine nitriles
09/24/2003EP1345901A2 Process for making amlodipine, derivatives thereof, and precursors therefor
09/24/2003EP1345900A1 Guanidine and amidine derivatives as factor xa inhibitors
09/24/2003EP1345899A1 Compounds
09/24/2003EP1345607A1 Therapeutic combination of amlodipine and benazepril / benazeprilat
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003EP0944598B1 Substituted benzamide derivatives and pharmaceutical compositions containing them
09/24/2003CN1444587A Dihydropyridine soft drug and related to composition and method
09/24/2003CN1444584A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444561A Acetamide derivatives and use thereof as inhibitors of coagulation factors XA and VIIA
09/24/2003CN1122023C Process for preparation of amlodipine benzenesulphonate
1 ... 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 ... 380